AAAAAA

   
Results: 1-10 |
Results: 10
Role of short-term inhibition of factor Xa by FXV673 in arterial passivation: A study in a chronic model of thrombosis in conscious dogs
Authors: Rebello, SS Kasiewski, CJ Wang, W Bentley, RG Morgan, SR Chu, V Colussi, D Brown, K Perrone, MH Leadley, RJ
Citation: Ss. Rebello et al., Role of short-term inhibition of factor Xa by FXV673 in arterial passivation: A study in a chronic model of thrombosis in conscious dogs, J CARDIO PH, 38(2), 2001, pp. 288-297
Pharmacological characterization of a novel factor Xa inhibitor, FXV673
Authors: Chu, V Brown, K Colussi, D Gao, JB Bostwick, J Kasiewski, C Bentley, R Morgan, S Guertin, K Pauls, HW Gong, Y Zulli, A Perrone, MH Dunwiddie, CT Leadley, RJ
Citation: V. Chu et al., Pharmacological characterization of a novel factor Xa inhibitor, FXV673, THROMB RES, 103(4), 2001, pp. 309-324
Superiority of enoxaparin over heparin in combination with a GPIIb/IIIa receptor antagonist during coronary thrombolysis in dogs
Authors: Rebello, SS Kasiewski, CJ Bentley, RG Morgan, SR Chu, V Bostwick, JS Klein, SI Perrone, MH Leadley, RJ
Citation: Ss. Rebello et al., Superiority of enoxaparin over heparin in combination with a GPIIb/IIIa receptor antagonist during coronary thrombolysis in dogs, THROMB RES, 102(3), 2001, pp. 261-271
Antithrombotic efficacy of a novel factor Xa inhibitor, FXV673, in a canine model of coronary artery thrombolysis
Authors: Rebello, SS Bentley, RG Morgan, SR Kasiewski, CJ Chu, V Perrone, MH Leadley, RJ
Citation: Ss. Rebello et al., Antithrombotic efficacy of a novel factor Xa inhibitor, FXV673, in a canine model of coronary artery thrombolysis, BR J PHARM, 133(7), 2001, pp. 1190-1198
In vitro characterization of a novel factor Xa inhibitor, RPR 130737
Authors: Chu, V Brown, K Colussi, D Choi, YM Green, D Pauls, HW Spada, AP Perrone, MH Leadley, RJ Dunwiddie, CT
Citation: V. Chu et al., In vitro characterization of a novel factor Xa inhibitor, RPR 130737, THROMB RES, 99(1), 2000, pp. 71-82
RPR120844, a novel, specific inhibitor of coagulation factor Xa inhibits venous thrombosis in the rabbit
Authors: Bostwick, JS Bentley, R Morgan, S Brown, K Chu, V Ewing, WR Spada, AP Pauls, H Perrone, MH Dunwiddie, CT Leadley, RJ
Citation: Js. Bostwick et al., RPR120844, a novel, specific inhibitor of coagulation factor Xa inhibits venous thrombosis in the rabbit, THROMB HAEM, 81(1), 1999, pp. 157-160
Pharmacodynamic activity and antithrombotic efficacy of RPR120844, a novelinhibitor of coagulation factor Xa
Authors: Leadley, RJ Morgan, SR Bentley, R Bostwick, JS Kasiewski, CJ Heran, C Chu, W Brown, K Moxey, P Ewing, WR Pauls, H Spada, AP Perrone, MH Dunwiddie, CT
Citation: Rj. Leadley et al., Pharmacodynamic activity and antithrombotic efficacy of RPR120844, a novelinhibitor of coagulation factor Xa, J CARDIO PH, 34(6), 1999, pp. 791-799
Cardiovascular pharmacology of the adenosine A(1)/A(2)-receptor agonist AMP 579: Coronary hemodynamic and cardioprotective effects in the canine myocardium
Authors: McVey, MJ Smits, GJ Cox, BF Kitzen, JM Clark, KL Perrone, MH
Citation: Mj. Mcvey et al., Cardiovascular pharmacology of the adenosine A(1)/A(2)-receptor agonist AMP 579: Coronary hemodynamic and cardioprotective effects in the canine myocardium, J CARDIO PH, 33(5), 1999, pp. 703-710
Design and structure-activity relationships of potent and selective inhibitors of blood coagulation factor Xa
Authors: Ewing, WR Becker, MR Manetta, VE Davis, RS Pauls, HW Mason, H Choi-Sledeski, YM Green, D Cha, D Spada, AP Cheney, DL Mason, JS Maignan, S Guilloteau, JP Brown, K Colussi, D Bentley, R Bostwick, J Kasiewski, CJ Morgan, SR Leadley, RJ Dunwiddie, CT Perrone, MH Chu, V
Citation: Wr. Ewing et al., Design and structure-activity relationships of potent and selective inhibitors of blood coagulation factor Xa, J MED CHEM, 42(18), 1999, pp. 3557-3571
Pharmacological characterization of AMP 579, a novel adenosine A(1)/A(2) receptor agonist and cardioprotective
Authors: Merkel, L Rojas, CJ Jarvis, MF Cox, BF Fink, C Smits, GJ Spada, AP Perrone, MH Clark, KL
Citation: L. Merkel et al., Pharmacological characterization of AMP 579, a novel adenosine A(1)/A(2) receptor agonist and cardioprotective, DRUG DEV R, 45(1), 1998, pp. 30-43
Risultati: 1-10 |